Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Bulletin of the World Health Organization

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7554025PMCID PMC2486776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced doses of hepatitis B vaccines: is it a good idea?

  1995cited by this paper
• Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.

  1992cited by this paper
• The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.

  1990cited by this paper
• Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore.

  1989cited by this paper
• The hepatitis B immunization programme in Singapore.

  1989cited by this paper
• Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

  1989cited by this paper
• The prevalence of hepatitis B virus markers in dental personnel in Singapore.

  1988cited by this paper
• Varying antibody response in hospital staff vaccinated against hepatitis B.

  1988cited by this paper
• Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.

  1988cited by this paper
• Low-dose hepatitis B vaccine immunisation in children.

  1987cited by this paper
• EARLY LOW‐DOSE HEPATITIS B VACCINE IN NEWBORN INFANTS: AN ECONOMIC OPTION FOR CONTROL IN ENDEMIC AREAS

  1987cited by this paper
• Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore.

  1986cited by this paper
• ROUND TABLE II: IMMUNOGENICITY AND SAFETY Moderator: Professor F. Deinhardt, Federal Republic of Germany Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose

  1986cited by this paper
• Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

  1986cited by this paper
• Low dose hepatitis B vaccination in children.

  1986cited by this paper
• Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.

  1986cited by this paper
• Immunogenicity of a five‐microgram dose of hepatitis B vaccine

  1985cited by this paper
• Immunogenicity of low doses of hepatitis B vaccine in normal children.

  1985cited by this paper
• Immunogenicity of low dose (1.25 and 0.31 micrograms) hepatitis B vaccine.

  1984cited by this paper
• The immune response of healthy nigerian adults to small doses of hepatitis B vaccine: Comparison of 10‐ and 20‐μg doses

  1984cited by this paper
• Immunogenicity of low dose (1.25 and 0.31 micrograms) hepatitis B vaccine.

  1984cited by this paper
• Immunogenicity and safety of a plasma-derived heat-inactivated hepatitis B vaccine (CLB). Studies in volunteers at a low risk of infection with hepatitis B virus.

  1984cited by this paper
• Safety and immunogenicity of a further reduced dose (10 mcg) of the hepatitis B vaccine.

  1983cited by this paper
• Reduction of the dose of hepatitis B vaccine.

  1983cited by this paper
• Aspects of vaccination against hepatitis B; passive-active immunization schedules and vaccination responses in different age groups.

  1983cited by this paper

• Achieving a Cure: The Next Frontier in Hepatitis B Treatment

  2021cites this paper
• Comparing monovalent and combination hepatitis B vaccine outcomes in children delivered by mothers with chronic hepatitis B

  2018cites this paper
• Booster dose vaccination for preventing hepatitis B.

  2016cites this paper
• Faktor-Faktor yang Berhubungan dengan Kadar Anti-Hbs pada Anak Sekolah Dasar Setelah 10-12 Tahun Imunisasi Hepatitis B Di Kota Padang

  2016cites this paper
• Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review.

  2013cites this paper
• Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008–2010

  2013cites this paper
• InfectionPrevention of Hepatitis B Virus Update on Diagnosis, Management,

  2010cites this paper
• Booster dose vaccination for preventing hepatitis B.

  2010cites this paper
• Changing seroprevalence of hepatitis B virus markers of adults in Singapore.

  2010cites this paper
• Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

  2010cites this paper
• A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.

  2010cites this paper
• Persistence of immunity and seroprotection 4 years after a primary vaccination schedule with a Hansenula polymorpha recombinant hepatitis B vaccine.

  2003cites this paper
• The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers

  2003cites this paper
• Hepatitis B vaccines.

  2003cites this paper
• Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa.

  2002cites this paper
• Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response

  2001cites this paper
• Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects.

  2001cites this paper
• Efectividad absoluta y relativa de la vacunación antihepatitis B en niños de Quillabamba, Perú, 1997-1999

  2000cites this paper
• Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection

  1999cites this paper
• Efficacy of low dose intra-dermal hepatitis B vaccination schedule.

  1998cites this paper
• Factores asociados a una respuesta inadecuada a la vacunación contra la hepatitis B en personal sanitario

  1998cites this paper
• Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.

  1997cites this paper
• Reduced doses of hepatitis B vaccines: is it a good idea?

  1995cites this paper
• Key Recent Literature

  1995cites this paper